相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Plasminogen and plasmin in Alzheimer's disease
Rachel Barker et al.
BRAIN RESEARCH (2010)
Endothelin-Converting Enzyme-2 Is Increased in Alzheimer's Disease and Up-Regulated by Aβ
Jennifer C. Palmer et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain
Shay Fabbro et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Angiotensins in Alzheimer's disease - friend or foe?
Patrick G. Kehoe et al.
TRENDS IN NEUROSCIENCES (2009)
Enhanced clearance of Aβ in brain by sustaining the plasmin proteolysis cascade
J. Steven Jacobsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Upregulation of tPA/plasminogen proteolytic system in the periphery of amyloid deposits in the Tg2576 mouse model of Alzheimer's disease
Joo-Yong Lee et al.
NEUROSCIENCE LETTERS (2007)
Ageing and amyloid-beta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms
Mathias Cacquevel et al.
NEUROBIOLOGY OF DISEASE (2007)
Cholinesterase inhibitors reduce cortical Aβ in dementia with Lewy bodies
C. G. Ballard et al.
NEUROLOGY (2007)
Neuroserpin binds Aβ and is a neuroprotective component of amyloid plaques in Alzheimer disease
Kerri J. Kinghorn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
beta-amyloid degradation and Alzheimer's disease
Deng-Shun Wang et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2006)
Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation
MG Medina et al.
EMBO JOURNAL (2005)
Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective
RE Tanzi et al.
CELL (2005)
Inhibition of apoptosis and caspase-3 in vascular smooth muscle cells by plasminogen activator inhibitor type-1
YB Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
APOE ε4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of Aβ protein
K Chalmers et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2003)
Urokinase-type plasminogen activator inhibits amyloid-β neurotoxicity and fibrillogenesis via plasminogen
HM Tucker et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Angiotensin-converting enzyme degrades Alzheimer amyloid β-peptide (Aβ);: Retards Aβ aggregation, deposition, fibril formation, and inhibits cytotoxicity.
JG Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Deficient release of plasminogen activator inhibitor-1 from astrocytes triggers apoptosis in neuronal cells
S Soeda et al.
MOLECULAR BRAIN RESEARCH (2001)
Degradation of the Alzheimer's amyloid β peptide by endothelin-converting enzyme
EA Eckman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Immunohistochemical localization of plasminogen activator inhibitor-1 in rat and human brain tissues
H Hino et al.
NEUROSCIENCE LETTERS (2001)
Downregulation of urokinase-type plasminogen activator receptor (uPAR) induces caspase-mediated cell death in human glioblastoma cells
N Yanamandra et al.
CLINICAL & EXPERIMENTAL METASTASIS (2001)
Tissue plasminogen activator requires plasminogen to modulate amyloid-β neurotoxicity and deposition
HM Tucker et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory
P Calabresi et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
分享论文
